20h
CarsGuide on MSNMG heads upmarket! New IM5 sedan and IM6 SUV arriving in Australia in 2025 to take on Tesla Model 3, XPeng G6 and BYD Sealion 7 electric carsMG will take another swipe at Tesla and XPeng by launching the IM electric car sub-brand in Australia this year. The brand is ...
Motoring USA on MSN3h
MG's electrifying five star MGS5 EV models confirmed [Photo Gallery]MG has confirmed today that the all-new MGS5 EV will be available from next month in the UK and in Quarter 2 in European ...
10h
Just Auto on MSNMG adds MGS5 EV model to rangeSAIC-owned MG has announced that the new MGS5 EV will be available from next month in the UK and in Q2 across European ...
Long-term nemolizumab use reduces itch, disease severity, and steroid dependence in patients with prurigo nodularis in a ...
Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi ...
11h
Zacks.com on MSNNovo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.
Can you please explain what is cholesterol/high-density lipoprotein and the significance of a high HDL cholesterol value? What about non-HDL cholesterol? I have had cholesterol tests for ...
CarsGuide.com.au on MSN2h
No more petrol or diesel? 2026 Kia Sportage to go hybrid-only for next generation to better rival Toyota RAV4 and Mazda CX-5: reportKia will no longer offer purely petrol and diesel engines in its Sportage range as the brand alters the line-up to be ...
ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.
15h
GlobalData on MSNRactigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancerThe company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
Kezar Life Sciences reports positive Phase 2a data for zetomipzomib in autoimmune hepatitis, showing higher response rates and reduced steroid use.
Equities research analysts at Scotiabank issued their FY2026 earnings per share estimates for Magna International in a research report issued to clients and investors on Wednesday, March 19th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results